1
Pennings, Elise R.A., Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F.M., Issa, Djamila E., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.
Veröffentlicht in: Pennings , E R A , Durmaz , M , Visser , O , Posthuma , E F M , Issa , D E , Chamuleau , M E D , Lugtenburg , P J , Kersten , M J & Dinmohamed , A G 2024 , ' Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma : a contemporary, nationwide, population-based study in the Netherlands ' , Blood Cancer Journal , vol. 14 , no. 1 , 3 . https://doi.org/10.1038/s41408-023-00970-z;
2024
Veröffentlicht in: Pennings , E R A , Durmaz , M , Visser , O , Posthuma , E F M , Issa , D E , Chamuleau , M E D , Lugtenburg , P J , Kersten , M J & Dinmohamed , A G 2024 , ' Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma : a contemporary, nationwide, population-based study in the Netherlands ' , Blood Cancer Journal , vol. 14 , no. 1 , 3 . https://doi.org/10.1038/s41408-023-00970-z;
2024
2
3
Amaador, Karima, Kersten, Marie José, Visser, Hein P. J., Nieuwenhuizen, Laurens, Schop, Roelandt F. J., Chamuleau, Martine E. D., Velders, Gerjo A., Minnema, Monique C., Vos, Josephine Mathilde Iris
Veröffentlicht in: Amaador , K , Kersten , M J , Visser , H P J , Nieuwenhuizen , L , Schop , R F J , Chamuleau , M E D , Velders , G A , Minnema , M C & Vos , J M I 2022 , ' First-Line Treatment of Waldenström’s Macroglobulinaemia : Considerations Based on the Dutch National Guideline ' , Hemato , vol. 3 , no. 4 , pp. 704-717 . https://doi.org/10.3390/hemato3040047;
2022
Veröffentlicht in: Amaador , K , Kersten , M J , Visser , H P J , Nieuwenhuizen , L , Schop , R F J , Chamuleau , M E D , Velders , G A , Minnema , M C & Vos , J M I 2022 , ' First-Line Treatment of Waldenström’s Macroglobulinaemia : Considerations Based on the Dutch National Guideline ' , Hemato , vol. 3 , no. 4 , pp. 704-717 . https://doi.org/10.3390/hemato3040047;
2022
4
Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F.M., Brouwer, Rolf E., Issa, Djamila E., de Jong, Daphne, Lam, King H., Blijlevens, Nicole M.A., Zijlstra, Josée M., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.
Veröffentlicht in: Durmaz , M , Visser , O , Posthuma , E F M , Brouwer , R E , Issa , D E , de Jong , D , Lam , K H , Blijlevens , N M A , Zijlstra , J M , Chamuleau , M E D , Lugtenburg , P J , Kersten , M J & Dinmohamed , A G 2022 , ' Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage : a nationwide, population-based study in the Netherlands, 1989–2018 ' , Blood Cancer Journal , vol. 12 , no. 3 , 38 . https://doi.org/10.1038/s41408-022-00637-1;
2022
Veröffentlicht in: Durmaz , M , Visser , O , Posthuma , E F M , Brouwer , R E , Issa , D E , de Jong , D , Lam , K H , Blijlevens , N M A , Zijlstra , J M , Chamuleau , M E D , Lugtenburg , P J , Kersten , M J & Dinmohamed , A G 2022 , ' Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage : a nationwide, population-based study in the Netherlands, 1989–2018 ' , Blood Cancer Journal , vol. 12 , no. 3 , 38 . https://doi.org/10.1038/s41408-022-00637-1;
2022
5
Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F. M., Brouwer, Rolf E., Issa, Djamila E., de Jong, Daphne, Lam, King H., Blijlevens, Nicole M. A., Zijlstra, Josée M., Chamuleau, Martine E. D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.
Veröffentlicht in: Blood Cancer Journal ; volume 12, issue 3 ; ISSN 2044-5385;
2022
Veröffentlicht in: Blood Cancer Journal ; volume 12, issue 3 ; ISSN 2044-5385;
2022
6
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie José, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
7
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S.P., Zijlstra, Josée M., Chamuleau, Martine E.D., Kersten, Marie José, Plattel, Wouter J., Durmaz, Mujde, Lugtenburg, Elly, Stevens, Wendy B.C., Mous, Rogier, de Vries, Elisabeth G.E., van der Poel, Marjolein W.M., Nannan Panday, Prashant V., Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M E D , Kersten , M J , Plattel , W J , Durmaz , M , Lugtenburg , E , Stevens , W B C , Mous , R , de Vries , E G E , van der Poel , M W M , Nannan Panday , P V , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood advances , vol. 5 , no. 15 , pp. 2985-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M E D , Kersten , M J , Plattel , W J , Durmaz , M , Lugtenburg , E , Stevens , W B C , Mous , R , de Vries , E G E , van der Poel , M W M , Nannan Panday , P V , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood advances , vol. 5 , no. 15 , pp. 2985-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
8
Spanjaart, Anne M., Pennings, Elise R.A., Mutsaers, Pim G.N.J., van Dorp, Suzanne, Jak, Margot, van Doesum, Jaap A., de Boer, Janneke W., Niezink, Anne G.H., Kos, Milan, Vermaat, Joost S.P., Sijs-Szabo, Aniko, van der Poel, Marjolein W.M., Nijhof, Inger S., Kuipers, Maria T., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Doorduijn, Jeanette K., Serroukh, Yasmina I.M., Minnema, Monique C., van Meerten, Tom, Kersten, Marie José
Veröffentlicht in: Spanjaart , A M , on behalf of the Dutch CAR-T Tumorboard Consortium , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023
Veröffentlicht in: Spanjaart , A M , on behalf of the Dutch CAR-T Tumorboard Consortium , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023